Adona Medical, a privately held portfolio company of Shifamed, was founded with the mission to innovate interventional approaches for treating heart failure, a condition affecting millions globally. The company's vision is to enhance patient care through advanced medical technology. Adona Medical offers a novel interatrial shunt with integrated bi-atrial pressure monitoring, enabling individualized management of heart failure by allowing shunting flow adjustments over time. Their primary market focus includes both the U.S. and global patient populations suffering from this progressive condition.

Notable affiliated individuals include key figures from Shifamed, a well-regarded medical technology incubator. Adona Medical has achieved significant milestones in developing their interatrial shunt technology, which features bi-atrial pressure sensors and an adjustable shunt lumen for post-implant modifications. This innovation has the potential to transform heart failure treatment by providing more precise and adaptable patient care, thereby making a substantial impact on the global healthcare landscape.